A mutation in the DNMT1 gene underlies HSNDDS, which combines sensory neuropathy, progressive hearing loss and dementia, a mix easily taken for other disorders.
Identifying a homozygous COQ7 variant confirms HSP47 and places it among COQ7-related disorders, alongside the progressive leg weakness and spasticity patients notice.
Faults in the HPS3 gene disturb lysosome-related organelles. Care can include regular eye exams, skin protection and watching for bleeding and pulmonary fibrosis.
Melanosomes give skin, hair and eyes their color; HPS4 mutations disrupt how they form, alongside bleeding problems and sometimes pulmonary fibrosis or colitis.
Platelet dysfunction causes prolonged bleeding in HPS5, which also brings hypopigmentation of skin, hair and eyes and a risk of pulmonary fibrosis over time.
Interstitial lung disease and oculocutaneous albinism define HPS-6. Treatment may involve supplemental oxygen, corticosteroids, antifibrotics or lung transplant.
People with HPS-7 may show hypopigmentation, bleeding tendencies and lung problems, all traced to DTNBP1 changes that disturb lysosome-related organelles.
BLOC1S3 mutations sit behind HPS-8, combining oculocutaneous albinism, bleeding problems and pulmonary fibrosis, as a reported case of respiratory failure illustrates.